KFI
REGN icon

Key Financial Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Key Financial Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Hold
210
– – 0.02% 376
2026
Q1 		$162K Hold
210
– – 0.03% 321
2025
Q4 		$162K Sell
210
-71
-25% -$48.2K 0.03% 326
2025
Q3 		$169K Sell
281
-26
-8% -$14.7K 0.03% 317
2025
Q2 		$161K Hold
307
– – 0.03% 311
2025
Q1 		$195K Hold
307
– – 0.04% 270
2024
Q4 		$219K Hold
307
– – 0.05% 241
2024
Q3 		$323K Buy
307
+1
+0.3% +$1.11K 0.07% 200
2024
Q2 		$322K Hold
306
– – 0.08% 185
2024
Q1 		$295K Hold
306
– – 0.08% 187
2023
Q4 		$269K Hold
306
– – 0.07% 188
2023
Q3 		$252K Hold
306
– – 0.08% 179
2023
Q2 		$220K Buy
306
+35
+13% +$27K 0.07% 197
2023
Q1 		$223K Buy
271
+195
+257% +$147K 0.08% 183
2022
Q4 		$52.4K Hold
76
– – 0.02% 351
2022
Q3 		$52K Hold
76
– – 0.02% 355
2022
Q2 		$45K Hold
76
– – 0.02% 381
2022
Q1 		$53K Buy
76
+71
+1,420% +$44.9K 0.03% 354
2021
Q4 		$3K Buy
+5
New +$3.07K ﹤0.01% 791
2020
Q2 		– Sell
-105
Closed -$50K – 501
2020
Q1 		$50K Buy
+105
New +$43.3K 0.05% 212

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Key Financial Inc's REGN Position: Q2 2026 in Review

Key Financial Inc held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 210 shares worth $131K. The position accounts for 0.02% of the portfolio, ranked #376.

Key Financial Inc first reported a position in REGN in Q1 2020 and has held it in 20 quarters since. The position peaked at $323K in Q3 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Key Financial Inc held 210 shares of Regeneron Pharmaceuticals worth $131K as of Q2 2026.
  • Key Financial Inc left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.02% of Key Financial Inc's portfolio in Q2 2026, its #376 holding.
  • Key Financial Inc first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 20 quarters since.
  • Key Financial Inc's Regeneron Pharmaceuticals position peaked at $323K in Q3 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.